Invitae Co. (NYSE:NVTA) Receives $10.33 Average Price Target From Analysts
Invitae Co. (NYSE:NVTA) Receives $10.33 Average Price Target From Analysts
Shares of Invitae Co. (NYSE:NVTA – Get Rating) have been given an average recommendation of "Hold" by the thirteen ratings firms that are presently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating and eight have assigned a hold rating to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $8.45.
邀請函股份有限公司(NYSE: NVTA — 獲得評分) 目前正在報導該公司的十三家評級公司「Marketbeat 評級」報告已經給予了「持有」的平均建議。四位投資分析師對該股票的賣出評級進行了評級，而八位則為該公司分配了持有評級。去年更新了股票覆蓋範圍的經紀公司的平均 1 年價格目標為 8.45 美元。
NVTA has been the subject of a number of research reports. StockNews.com raised shares of Invitae to a "sell" rating in a research note on Friday. SVB Leerink lifted their price objective on shares of Invitae from $2.50 to $3.00 and gave the company a "market perform" rating in a research note on Wednesday, November 9th. Cowen lowered shares of Invitae from an "outperform" rating to a "market perform" rating in a research note on Tuesday, July 26th. Credit Suisse Group initiated coverage on shares of Invitae in a research note on Wednesday, August 24th. They issued an "underperform" rating for the company. Finally, Cowen lifted their price objective on shares of Invitae to $2.80 in a research note on Tuesday, November 15th.
NVTA 一直是許多研究報告的主題。Stocknews.com 在周五的一份研究報告中將邀請函的股份提高到「賣出」評級。SVB Leerink 在 11 月 9 日（星期三）的一份研究報告中將其對邀請函股票的價格目標從 2.50 美元提高至 3.00 美元，並在該研究報告中給予該公司「市場表現」評級。考恩在 7 月 26 日（星期二）的研究報告中將邀請賽的股票從「跑贏大市」評級降至「市場表現」評級。瑞士信貸集團於 8 月 24 日（星期三）在一份研究報告中發起對 Esse8ae 股份的覆蓋範圍。他們為公司頒發了「表現不足」的評級。最後，考恩在 11 月 15 日（星期二）的一份研究報告中將其對邀請賽股票的價格目標提升至 2.80 美元。
Invitae Stock Performance
邀請函股票表演
Invitae stock opened at $2.74 on Tuesday. The company has a 50 day moving average price of $2.63 and a 200 day moving average price of $2.95. Invitae has a 52 week low of $1.83 and a 52 week high of $18.87. The company has a quick ratio of 6.18, a current ratio of 6.44 and a debt-to-equity ratio of 10.03.
邀請函股票在周二開盤 2.74 美元。該公司有一個 50 日移動平均價格為 2.63 美元，200 日移動平均價格為 2.95 美元。邀請賽有 52 周低點的 1.83 美元和 52 周高點 18.87 美元。該公司的快速比率為 6.18，流動比率為 6.44，債務與權益比率為 10.03。
Institutional Inflows and Outflows
機構流入和流出
Institutional investors and hedge funds have recently made changes to their positions in the stock. Financial Advocates Investment Management bought a new position in shares of Invitae during the 3rd quarter worth about $206,000. Operose Advisors LLC bought a new stake in Invitae in the first quarter valued at about $32,000. AdvisorNet Financial Inc increased its stake in Invitae by 61.0% in the third quarter. AdvisorNet Financial Inc now owns 10,000 shares of the medical research company's stock valued at $25,000 after acquiring an additional 3,788 shares during the period. Credit Agricole S A bought a new stake in Invitae in the third quarter valued at about $25,000. Finally, Clearwater Capital Advisors LLC bought a new stake in Invitae in the first quarter valued at about $82,000. Institutional investors own 88.27% of the company's stock.
機構投資者和對沖基金最近對其股票的頭寸進行了更改。金融倡導者投資管理在第三季度期間購買了邀請賽股份的新位置，價值約為 206,000 美元。操作顧問有限責任公司在第一季度購買了邀請賽的新股份，價值約為 32,000 美元。顧問網金融公司在第三季度將其在邀請賽的股份增加了 61.0％。在此期間，顧問網金融公司現在擁有該醫學研究公司的 10,000 股股票，價值為 25,000 美元。法國農業信貸銀行 A 在第三季度購買了邀請函的新股份，價值約為 25,000 美元。最後，清水城資本顧問有限責任公司在第一季度購買了邀請賽的新股份，價值約為 82,000 美元。機構投資者擁有公司股票的 88.27%。
About Invitae
關於邀請函
(Get Rating)
(取得評分)
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services.
Inviae Corporation 是一家醫學遺傳學公司，將遺傳信息集成到主流醫學中，以改善美國，加拿大和國際上人們的醫療保健。該公司提供各種臨床領域的基因檢測，包括遺傳性癌症、心臟科、神經科、兒科、腫瘤學、代謝狀況和罕見疾病；數位健康解決方案；以及健康資料服務。
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on Invitae (NVTA)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here's What Needs to Happen
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Ardelyx is A Buy After Slip in Early 2022
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
- 免費獲取有關邀請賽的研究報告
- 贏得在線賭博行業的三種方法
- 聖誕老人拉力賽？這是需要發生的事情
- 鮑勃·伊格爾的歸來會將魔法歸還給迪士尼股票嗎？
- 阿德利克斯是 2022 年初滑倒後的買入嗎
- 特斯拉現在是否討價還價，因為它交易在兩年低點？
Receive News & Ratings for Invitae Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invitae and related companies with MarketBeat.com's FREE daily email newsletter.
接收每日邀請函的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件時事通訊接收邀請函和相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。